Saturday 10 August 2013

Advanced Cancer Of The Lungs In Some Patients Can Be Cured By The Drug Iressa

Advanced Cancer Of The Lungs In Some Patients Can Be Cured By The Drug Iressa.
Advanced lung cancer is notoriously unyielding to treat, but a set of Japanese scientists reports that a cancer downer known as Iressa was significantly more operational than example chemotherapy for patients with a indubitable genetic profile. These patients have an advanced custom of the most common type of lung cancer - non-small room lung cancer - and a mutation of a protein found on the show up of certain cells that causes them to divide pillarder.com. This protein - known as epidermal intumescence factor receptor (EGFR) - is found in unusually pongy numbers on the surface of some cancer cells.

The researchers focused on gefitinib (Iressa), which stops the protein receptor from sending a letter to the cancer cells to pit and grow. In their study, reported in the June 24 printing of the New England Journal of Medicine, the hypnotic had a better safety survey and improved survival time with no cancer progression in a significantly higher share of patients than did standard chemotherapy.

Researchers from the respiratory medicine department at the Tohoku University Hospital in Sendai, Japan chose to look into gefitinib in put because standard cancer treatments -including surgery, shedding and chemotherapy - fail to cure most cases of non-small cubicle lung cancer. From clinical trials, the researchers also knew that non-small apartment lung cancers in rank and file with a sensitive EGFR mutation were very responsive to gefitinib, but little was known about the medication's protection profile or effectiveness compared with typical chemotherapy.

For this reason, Dr Akira Inoue and his colleagues focused on 230 patients with the EGFR transmutation and metastatic non-small-cell lung cancer; the patients were treated in 43 dissimilar medical facilities between 2006 and 2009 throughout Japan. In a randomized case-control study, half were given gefitinib, while the others received guidon chemotherapy.

After an common bolstering of about 17 months, the research tandem found that while 73,7 percent of the gefitinib patients responded positively to their treatment, only 30,7 percent of the chemotherapy patients did so. The malicious survival set with no cancer progression was significantly higher centre of the gefitinib group - 10,8 months, compared to 5,4 months all the chemotherapy group. In addition, one and two-year survival rates were, respectively, 42,1 percent and 8,4 percent amongst those in the gefitinib group, compared to 3,2 and nada middle those in the chemotherapy group.

Wednesday 31 July 2013

Dysfunction Of The Autonomic Nervous System May Be A Marker Of Later Development Of Certain Types Of Kidney Disease

Dysfunction Of The Autonomic Nervous System May Be A Marker Of Later Development Of Certain Types Of Kidney Disease.
A person's empathy spent may proposition discernment into their tomorrow kidney health, a new study suggests canada. A high-priced resting heart rate and low beat-to-beat quintessence rate variability were noted in study patients with an increased endanger for kidney disease, according to a report released online July 8 in go on of publication in an upcoming print issue of the Journal of the American Society of Nephrology.

The find suggests that dysfunction of the autonomic highly-strung system - which regulates involuntary body functions such as fundamentals rate, blood pressure, temperature and stress effect - may be a marker for late development of certain types of kidney disease, explained Dr Daniel Brotman of Johns Hopkins University School of Medicine and colleagues, in a information publicity release from the American Society of Nephrology. Previous studies have suggested a associate between autonomic troubled system dysfunction (dysautonomia) and chronic kidney condition and its progression.

Monday 22 July 2013

Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes

Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes.
A unexplored drug, the essential in its class, gives added blood sugar device to living souls with type 2 diabetes who are already fascinating the glucose-lowering medication metformin. The new agent, dapagliflozin, which also helped patients elude weight, is novel in that it does not position directly on the body's insulin mechanisms, according to a study appearing in the June 26 son of The Lancet and slated for presentation at the annual engagement of the American Diabetes Association (ADA) in Orlando wheretobuyrx. "It will perhaps be used as an add-on therapy," said bookwork lead author Clifford Bailey, a chemical pathologist and professor of clinical information at Aston University in Birmingham, UK "If you don't undoubtedly get to target with the first therapy tried , this closer would offer you an opportunity hopefully to maintain improved control".

Bailey, who could not augur if or when the drug might get final approval from numb regulatory authorities, also pointed out that dapagliflozin is flexible, meaning it can be employed with various other treatments and at more or less any stage in the disease. "It's a good add-on," agreed Dr Stanley Mirsky, associated clinical professor of metabolic diseases at Mount Sinai Medical Center in New York City. "Is it a awe drug? No. It may disport a shallow role".

The study was funded by Bristol-Myers Squibb and AstraZeneca, which are developing dapagliflozin together. Dapagliflozin factory by thought-provoking the kidneys to eliminate more glucose from the body via urine. In this consider of 534 adult patients with type 2 diabetes who were already prepossessing metformin, the highest dose of dapagliflozin (10 milligrams daily) was associated with a 0,84 percent subsidence in HbA1c levels.

HbA1c is a metre of blood sugar control over time. Participants engaging 5 mg of the drug saw a 0,70 percent dwindling in HbA1c levels, while those taking 2.5 mg had a 0,67 percent decrease. In the placebo group, the subside in HbA1c was 0,3 percent, the scrutiny found.

Tuesday 16 July 2013

Non-Invasive Diagnosis Of Traumatic Dementia At An Early Stage

Non-Invasive Diagnosis Of Traumatic Dementia At An Early Stage.
A "virtual biopsy" may facilitate analyse a degenerative wit disorder that can occur in gifted athletes and others who suffer repeated blows to the head, says a original study. Symptoms of chronic traumatic encephalopathy (CTE) can allow for memory problems, impulsive and erratic behavior, downturn and, eventually, dementia canada. The condition, which is noticeable by an accumulation of abnormal proteins in the brain, can only be diagnosed by an autopsy.

But a specialized imaging ability called magnetic resonance spectroscopy (MRS) may sell a noninvasive way to diagnose CTE at an first stage so that treatment can begin before further brain damage occurs, say US researchers. MRS - occasionally referred to as "virtual biopsy" - uses compelling magnetic field and present waves to gather information about chemical compounds in the body. The researchers second-hand MRS to examine five retired seasoned male football players, wrestlers and boxers, ages 32 to 55, with suspected CTE and compared them to a lead team of five age-matched men.

Thursday 4 July 2013

Reducing Mortality From Coronary Heart Disease

Reducing Mortality From Coronary Heart Disease.
Improved treatment, coupled with more useful curb measures, may be having a convincing impact on the death rate from coronary sensitivity disease. Death rate data from the United States and Canada both say a drop in cardiovascular deaths buying. According to the American Heart Association, the annual eradication rate from coronary centre disease from 1996 to 2006 declined 36,4 percent and the tangible death rate dropped 21,9 percent.

In Canada, according to a lessons in the May 12 issue of the Journal of the American Medical Association, the annihilation rate from coronary heart disease in the responsibility of Ontario fell by 35 percent from 1994 to 2005. "The overall goodness news is that coronary heart mortality continued to go down in defiance of people growing older," said study novelist Dr Harindra C Wijeysundera, a cardiologist at the Sunnybrook Health Sciences Centre Schulich Heart Centre in Toronto. "Risk determinant changes appear to against a very important role," he said, "accounting for just under half the increase despite increasing availability of better treatments". And, he added, "the strange therapies are being well-used".

But there is a cloud on the view that darkens the generally cheery report, Wijeysundera noted. "Diabetes and avoirdupois are on the increase," he said. "It doesn't entertain much of a negative trend in diabetes and obesity to drop the good trends". A 1 percent increase in diabetes correlates to a 6 percent raise in mortality, he said.

Wednesday 26 June 2013

Moderate Consumption Of Coffee Or Tea Reduces The Risk Of Heart Disease

Moderate Consumption Of Coffee Or Tea Reduces The Risk Of Heart Disease.
Drinking coffee or tea in moderation reduces the jeopardize of developing empathy disease, and both tipsy and deliberate tea drinking reduces the jeopardy of dying from the condition, according to a large-scale study from Dutch researchers penises. The study, led by physicians and researchers at the University Medical Center Utrecht, examined material on coffee and tea consumption from 37,514 residents of The Netherlands who were followed for 13 years.

It found that men and women who had two to four cups a lifetime of coffee had a 20 percent lop off gamble of heart disease compared to those drinking less than two or more than four cups a day. Moderate coffee intake also marginally - but not significantly - reduced the endanger of finish from heart disease and all causes.

Tea's performance was stronger on both counts. Drinking three to six cups of tea a daytime was associated with a 45 percent reduced chance of death from soul disease, compared to drinking less than one cup a day, and drinking more than six cups of tea a hour was associated with a 36 percent drop risk of getting heart disease in the first place.

The clear protective effects may be linked to antioxidants and other plant chemicals in the beverages, but how they wield is unclear, according to researchers. No effect of coffee or tea consumption on the peril of stroke was seen in the study. Study authors found, however, that coffee and tea drinkers in The Netherlands had very abundant fitness behaviors, with more coffee drinkers smoking and having less trim diets.

Dr Suzanne Steinbaum, director of women and marrow disease at Lenox Hill Hospital in New York City and a spokeswoman for the American Heart Association, prominent that there has been continued controversy about the impact of daily tea and coffee consumption on health. "Here is another deliberate over that reaffirms there is no increased risk of crux disease and stroke, and in fact, when drinking coffee in moderation, there is Deo volente a reduction in your risk of heart disease," she wrote on behalf of the AHA.

Experts note, however, that it's too anciently to make established recommendations on coffee and tea drinking for the sake of better health, without thought a growing number of studies that suggest the beverages may help nurture against heart disease. "Based on current evidence, it is very difficult to come up with an paragon amount of coffee or tea for the general population," said Dr Frank Hu, professor of nutrition and epidemiology at the Harvard School of Public Health.

Sunday 16 June 2013

Daily Drinking Green Tea Or Coffee Can Reduce The Risk Of Stroke

Daily Drinking Green Tea Or Coffee Can Reduce The Risk Of Stroke.
Many common man gobble up coffee or tea breaks throughout the day, and that basic performance may help them reduce their risk for stroke, Japanese researchers report. This swot of about 83000 people suggests that drinking untrained tea or coffee daily might degrade stroke risk by about 20 percent, with even more protection against a specific paradigm of stroke rxlist box com. "The regular action of daily drinking of leafy tea and coffee is a benefit in preventing stroke," said be first researcher Dr Yoshihiro Kokubo, chief falsify in the department of preventive cardiology at the National Cerebral and Cardiovascular Center, in Osaka.

So "If you cannot instantly improve your lifestyle, whack to prevent stroke by drinking green tea every day," he said. Although it isn't unfailing why coffee and tea may have this effect, Kokubo thinks it might be due to undoubted properties in these drinks that keep blood from clotting. In addition, unripe tea contains catechins, which have an antioxidant, anti-inflammatory effect.

Some chemicals in coffee, such as chlorogenic acid, may curtailed the jeopardy of stroke by lowering the chances of developing prototype 2 diabetes, he explained. Coffee also contains caffeine, which may have an bumping on cholesterol levels and blood pressure, and may cause changes in insulin sensitivity, which affects blood sugar, he added. One expert, Dr Ralph Sacco, one-time president of the American Heart Association, cautioned that this model of contemplate cannot say for reliable that the lower risk of stroke is really the result of drinking coffee or tea.

Thursday 6 June 2013

Nickel Allergy From A Cell Phone

Nickel Allergy From A Cell Phone.
If you're an incessant stall phone alcohol and a dark rash appears along your jaw, cheek or ear, chances are you're allergic to nickel, a metal commonly Euphemistic pre-owned in apartment phones. While allergists have long been familiar with nickel allergy, "cell phone rash" is just starting to show up on their radar screen, said Dr Luz Fonacier, chairwoman of allergy and immunology at Winthrop University Hospital in Mineola, NY provillushop com. "Increased use of chamber phones with endless operation plans has led to prolonged communicating to the nickel in phones," said Fonacier, who is scheduled to converse about the condition in a larger presentation on skin allergies Nov 14, 2010 at the American College of Allergy, Asthma and Immunology annual assignation in Phoenix.

Symptoms of room phone allergy embrace a red, bumpy, itchy rash in areas where the nickel-containing parts of a cubicle phone touch the face. It can even sway fingertips of those who text continuously on buttons containing nickel. In monastic cases, blisters and itchy sores can develop.

Fonacier said she sees many patients who are allergic to nickel and don't separate it. "They come in with no hypothesis of what is causing their allergic reaction," said Fonacier, also a professor of clinical nostrum at the State University of New York at Stony Brook. Sometimes, she traces her patients' symptoms to their cell phones.

In 2000, a researcher in Italy documented the commencement casket of cell phone rash, prompting other scrutinize on the condition. In a 2008 workroom published in the Canadian Medical Association Journal, US researchers tested for nickel in 22 handsets from eight manufacturers; 10 contained the metal. The parts with the most nickel were the menu buttons, decorative logos on the headsets and the metal frames around the solution crystal betray (LCD) screens.

Cell phone unconsidered is still not well known, said allergist Dr Stanley M Fineman, a clinical buddy professor at the Emory University School of Medicine in Atlanta. While he's treated more cases of nickel allergy caused by piercings than by cell phones, "it's virtuousness for allergists and dermatologists to have cell phone touch dermatitis on their radar screens," he said.

Friday 24 May 2013

Diet And Exercise Are The Main For The Prevention Of Diabetes

Diet And Exercise Are The Main For The Prevention Of Diabetes.
Only 11 percent of the estimated 79 million Americans who are at imperil for diabetes skilled in they are at risk, federal robustness officials reported Thursday. The condition, known as prediabetes, describes higher-than-normal blood sugar levels that put mobile vulgus in hazard of developing diabetes, according to the US Centers for Disease Control and Prevention. "We have a large discharge with the unimaginative number of people who know they have it Prescription store dietrine tablet. It's up a grain from when we measured it last, but it's still abysmally low," said news author Ann Albright, guide of the CDC's Division of Diabetes Translation.

And "We need subjects to understand their risk and take action if they are at risk for diabetes," Albright said. "We positive how to prevent type 2 diabetes, or at least hold-up it, so there are things people can do, but the oldest step is knowing what your risk is - to grasp if you have prediabetes". Things that put people at risk for prediabetes include being overweight or obese, being physically non-functioning and not eating a healthy diet, Albright said. These persons should see their doctor and have their blood sugar levels checked, she said.

There is also a genetic component, Albright said, which is why having a children intelligence of diabetes is another risk factor. "Your genetics loads the gun, then your lifestyle pulls the trigger," she said. According to the report, published in the March 22 exit of the Morbidity and Mortality Weekly Report, the be of awareness of prediabetes was the same across the board, anyhow of income, education, well-being surety or access to health care.

Thursday 9 May 2013

Bisphosphonates Are Used In The Construction Of Bones Further Reduce The Risk Of Invasive Breast Cancer

Bisphosphonates Are Used In The Construction Of Bones Further Reduce The Risk Of Invasive Breast Cancer.
Bone-building drugs known as bisphosphonates appear to minimize the chance of invasive boob cancer by around 30 percent, two changed studies show. "If a maiden is bearing in mind bisphosphonate use for bone, this might be another potential benefit," said Dr Rowan T Chlebowski, a clinical oncologist at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center in Torrance, Calif fav-store. He is the be ahead architect of one of the two studies on the topic, published online this week in the Journal of Clinical Oncology.

The findings were opening presented time remain year at the San Antonio Breast Cancer Symposium, but Chlebowski said the results now have the further of having been peer-reviewed before quarterly for meticulous accuracy. Chlebowski and his colleagues looked at nearly 155000 women who participated in the Women's Health Initiative (WHI) study, evaluating the 2816 women who took said bisphosphonates at the sanctum jump and comparing them to women who did not.

Ninety percent of the women who were taking the bone-building drugs took alendronate (Fosamax), according to the study. After nearly eight years of follow-up, Chlebowski found invasive chest cancer number was 32 percent slash in those on bone-building drugs, with ER-positive cancers reduced by 30 percent. The occurrence of ER-negative cancers in those on bisphosphonates also decreased, but not by enough to be statistically significant.

The extent of early, noninvasive heart of hearts cancers, known as ductal carcinoma in situ, was 42 percent higher in bisphosphonate users, so the bisphosphonates could by crook be selectively affecting invasive cancers, Chlebowski postulated. In a approve study, conducted in Israel, researchers looked at 4039 postmenopausal women, including some who took bisphosphonates and some who did not. Those who took the cure-all longer than a year had a 39 percent reduced jeopardize of tit cancer; after adjusting for factors such as long time and subdivision history, there was still a risk reduction of 28 percent.